Cluster of HIV infections attributed to unsafe injection practices — Cambodia, december 1, 2014–february 28, 2015

Morbidity and Mortality Weekly Report

Volumn 65, Issue 6, 2016, Pages 142-145

  Vun, Mean Chhi ^a   Galang, Romeo R ^b   Fujita, Masami ^c   Killam, William ^d   Gokhale, Runa ^b   Pitman, John ^e   Selenic, Dejana ^e   Mam, Sovatha ^a   Mom, Chandara ^a   Fontenille, Didier ^f   Rouet, Francois ^f   Vonthanak, Saphonn ^g  

^a Cambodia National Center for HIV AIDS   (Cambodia)

^b Global AIDS Program   (Cambodia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e CDC

^f INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^g Cambodia University of Health Sciences   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; AGED; CAMBODIA; CHILD; CLUSTER ANALYSIS; EPIDEMIC; FEMALE; HIV INFECTIONS; HUMAN; INFANT; INJECTION; MALE; MIDDLE AGED;

AGED; CAMBODIA; CHILD; CLUSTER ANALYSIS; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INJECTIONS; MALE; MIDDLE AGED;

EID: 84959487119     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6506a2     Document Type: Article

References (10)

1. Yamada H, Fujimoto M, Svay S, et al. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia. Hepatol Res 2015;45:480–7. http://dx.doi.org/10.1111/hepr.12367.
2. National AIDS Authority. Cambodia country progress report: monitoring progress towards the targets of the 2011 UN Political Declaration on HIV and AIDS. Phnom Penh, Cambodia: National AIDS Authority; 2014. http://www.unaids.org/sites/default/files/country/documents//KHM_narrative_report_2014.pdf.
3. Vong S, Perz JF, Sok S, et al. Rapid assessment of injection practices in Cambodia, 2002. BMC Public Health 2005;5:56–62. http://dx.doi.org/10.1186/1471-2458-5-56.
4. Pépin J, Abou Chakra CN, Pépin E, Nault V. Evolution of the global use of unsafe medical injections, 2000–2010. PLoS One 2013;8:e80948. http://dx.doi.org/10.1371/journal.pone.0080948.
5. National Institute of Statistics; Directorate General for Health; ICF Macro. Cambodia demographic and health survey 2010. Phnom Penh, Cambodia: National Institute of Statistics, Directorate for General Health; Calverton, Maryland: ICF Macro; 2011. http://dhsprogram.com/pubs/pdf/FR249/FR249.pdf.
6. Schmid GP, Buvé A, Mugyenyi P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004;363:482–8. http://dx.doi.org/10.1016/S0140-6736(04)15497-4.
7. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS 2014;28:1509–19. http://dx.doi.org/10.1097/QAD.0000000000000298.
8. Conrad C, Bradley HM, Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone—Indiana, 2015. MMWR Morb Mortal Wkly Rep 2015;64:443–4.
9. Utyasheva L. Kyrgyzstan: nine health care workers guilty of negligence causing HIV transmission among children. HIV AIDS Policy Law Rev 2008;13:48–9.
10. Gisselquist D, Upham G, Potterat JJ. Efficiency of human immunodeficiency virus transmission through injections and other medical procedures: evidence, estimates, and unfinished business. Infect Control Hosp Epidemiol 2006;27:944–52. http://dx.doi.org/10.1086/506408.